ingredientsour brandssustainabilitywhy Givaudan?expert insightsContact Us

The science-backed botanical ingredient for metabolic health

back to
Novaberin™

Results from clinical research in overweight pre-diabetic individuals show that Novaberin™ supports multiple aspects of metabolic health, including healthy weight management, blood glucose and lipid support.¹ Standardized for efficacy, Novaberin™ was developed to deliver clinically meaningful benefits in a convenient solution.   In a randomized, placebo-controlled clinical study, overweight pre-diabetic adults supplemented 250 mg Novaberin™ twice daily with a meal for six months.¹ The research demonstrated statistically significant improvements across several metabolic health markers compared to placebo. 

14.8%
reduction in HbA1c

Weight management4

Clinical findings showed significant changes in body weight and composition. Subjects taking Novaberin™ showed ¹: 1. 6.9% reduction in body weight (4.8 kg or roughly 10 lbs)  2. 6.95% reduction in BMI  3. 2.7% reduction in waist circumference 

Blood sugar

The research showed significant reductions in key markers of glucose metabolism ¹:  1. 14.8% reduction in HbA1c  2. 28.9% reduction in post-meal glucose  3. 10.9% reduction in fasting plasma glucose  4. 47% reduction in HOMA-IR (Homeostatic Model Assessment of Insulin Resistance) 
Learn More

Lipid profile

The clinical research also demonstrated significant changes in key lipid markers associated with cardiovascular and metabolic health.¹  1. 22.1% reduction in triglycerides  2. 17.4% reduction in LDL cholesterol  3. 9.1% increase in HDL cholesterol  4. 10.1% reduction in total cholesterol 
Learn More

References
Disclaimer
This web page is intended to provide business-to-business education and information. Its purpose is not intended to communicate to end consumers. Ingredient information is for educational purposes only; specific ingredients are not intended to prevent, treat, mitigate or cure any disease states. This information is not intended to be used in final consumer products and any use or reference of the intellectual property of Givaudan in the final product may only be made with Givaudan’s prior written permission. The information provided may or may not be applicable to, or satisfy, all regulatory requirements for all global regions. Specific regulatory requirements must be evaluated to ensure compliance within the individual countries and regions.
contactsprivacy policyterms and conditions
*